{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:35:03Z","timestamp":1789695303214,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,11,26]],"date-time":"2002-11-26T00:00:00Z","timestamp":1038268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/1471-2407-2-31","type":"journal-article","created":{"date-parts":[[2002,12,17]],"date-time":"2002-12-17T12:08:11Z","timestamp":1040126891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Regular aspirin use and lung cancer risk"],"prefix":"10.1186","volume":"2","author":[{"given":"Kirsten B","family":"Moysich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi J","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Ronsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Swede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Michael","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L","family":"Falkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Loewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Bepler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,11,26]]},"reference":[{"key":"51_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","volume":"81","author":"JP Collet","year":"1999","unstructured":"Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L: Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer. 1999, 81: 62-68. 10.1038\/sj.bjc.6690651.","journal-title":"Br J Cancer"},{"key":"51_CR2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q","volume":"82","author":"L Rosenberg","year":"1998","unstructured":"Rosenberg L, Louik C, Shapiro S: Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer. 1998, 82: 2326-2333. 10.1002\/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q.","journal-title":"Cancer"},{"key":"51_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-4615-5325-0_53","volume":"400A","author":"MJ Thun","year":"1997","unstructured":"Thun MJ: Aspirin and gastrointestinal cancer. Adv Exp Med Biol. 1997, 400A: 395-402.","journal-title":"Adv Exp Med Biol"},{"key":"51_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/pmed.1995.1017","volume":"24","author":"LJ Marnett","year":"1995","unstructured":"Marnett LJ: Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer. Prev Med. 1995, 24: 103-106. 10.1006\/pmed.1995.1017.","journal-title":"Prev Med"},{"key":"51_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1084\/jem.190.4.445","volume":"190","author":"SJ Shiff","year":"1999","unstructured":"Shiff SJ, Rigas B: The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med. 1999, 190: 445-450. 10.1084\/jem.190.4.445.","journal-title":"J Exp Med"},{"key":"51_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0016-5085(98)70330-0","volume":"114","author":"RA Gupta","year":"1998","unstructured":"Gupta RA, DuBois RN: Aspirin, NSAIDS, and colon cancer prevention: mechanisms?. Gastroenterology. 1998, 114: 1095-1098.","journal-title":"Gastroenterology"},{"key":"51_CR7","first-page":"111","volume-title":"Eur J Surg Suppl","author":"DJ Ahnen","year":"1998","unstructured":"Ahnen DJ: Colon cancer prevention by NSAIDs: what is the mechanism of action?. Eur J Surg Suppl. 1998, 111-114. 10.1080\/11024159850191544."},{"key":"51_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3349\/ymj.1998.39.4.287","volume":"39","author":"SP Hong","year":"1998","unstructured":"Hong SP, Ha SH, Park IS, Kim WH: Induction of apoptosis in colon cancer cells by nonsteroidal anti-inflammatory drugs. Yonsei Med J. 1998, 39: 287-295.","journal-title":"Yonsei Med J"},{"key":"51_CR9","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF, Blot WJ: Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev. 1998, 7: 97-102.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"51_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB: Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995, 76: 1116-1119.","journal-title":"Cancer"},{"key":"51_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K","volume":"82","author":"D Zaridze","year":"1999","unstructured":"Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V: Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer. 1999, 82: 473-476. 10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K.","journal-title":"Int J Cancer"},{"key":"51_CR12","first-page":"933","volume":"9","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S: A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000, 9: 933-937.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"51_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1006\/pmed.2001.0945","volume":"33","author":"A Akhmedkhanov","year":"2001","unstructured":"Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Kato I, Koenig KL, Shore RE: Aspirin and epithelial ovarian cancer. Prev Med. 2001, 33: 682-687. 10.1006\/pmed.2001.0945.","journal-title":"Prev Med"},{"key":"51_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994, 5: 138-146.","journal-title":"Epidemiology"},{"key":"51_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/pmed.1999.0518","volume":"29","author":"PF Coogan","year":"1999","unstructured":"Coogan PF, Rao SR, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S: The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med. 1999, 29: 72-76. 10.1006\/pmed.1999.0518.","journal-title":"Prev Med"},{"key":"51_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","volume":"7","author":"RE Harris","year":"1996","unstructured":"Harris RE, Namboodiri KK, Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 1996, 7: 203-205.","journal-title":"Epidemiology"},{"key":"51_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","volume":"296","author":"R Peto","year":"1988","unstructured":"Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, et al: Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed). 1988, 296: 313-316.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"51_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/bmj.299.6710.1247","volume":"299","author":"A Paganini-Hill","year":"1989","unstructured":"Paganini-Hill A, Chao A, Ross RK, Henderson BE: Aspirin use and chronic diseases: a cohort study of the elderly. Bmj. 1989, 299: 1247-1250.","journal-title":"Bmj"},{"key":"51_CR19","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW: Aspirin use and risk of fatal cancer. Cancer Res. 1993, 53: 1322-1327.","journal-title":"Cancer Res"},{"key":"51_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/pmed.1995.1018","volume":"24","author":"L Rosenberg","year":"1995","unstructured":"Rosenberg L: Nonsteroidal anti-inflammatory drugs and cancer. Prev Med. 1995, 24: 107-109. 10.1006\/pmed.1995.1018.","journal-title":"Prev Med"},{"key":"51_CR21","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Bmj. 2000, 320: 1642-1646. 10.1136\/bmj.320.7250.1642.","journal-title":"Bmj"},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/sj.bjc.6600370","volume":"87","author":"A Akhmedkhanov","year":"2002","unstructured":"Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE: Aspirin and lung cancer in women. Br J Cancer. 2002, 87: 49-53. 10.1038\/sj.bjc.6600370.","journal-title":"Br J Cancer"},{"key":"51_CR23","first-page":"693","volume":"9","author":"RE Harris","year":"2002","unstructured":"Harris RE, Beebe-Donk J, Schuller HM: Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep. 2002, 9: 693-695.","journal-title":"Oncol Rep"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"JR Vane","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998, 38: 97-120. 10.1146\/annurev.pharmtox.38.1.97.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"51_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","volume":"90","author":"MM Taketo","year":"1998","unstructured":"Taketo MM: Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst. 1998, 90: 1529-1536. 10.1093\/jnci\/90.20.1529.","journal-title":"J Natl Cancer Inst"},{"key":"51_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/carcin\/21.4.543","volume":"21","author":"AK Bauer","year":"2000","unstructured":"Bauer AK, Dwyer-Nield LD, Malkinson AM: High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis. 2000, 21: 543-550. 10.1093\/carcin\/21.4.543.","journal-title":"Carcinogenesis"},{"key":"51_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/carcin\/18.5.1001","volume":"18","author":"C Duperron","year":"1997","unstructured":"Duperron C, Castonguay A: Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A\/J mice. Carcinogenesis. 1997, 18: 1001-1006. 10.1093\/carcin\/18.5.1001.","journal-title":"Carcinogenesis"},{"key":"51_CR28","first-page":"775","volume":"18","author":"T Hida","year":"1998","unstructured":"Hida T, Leyton J, Makheja AN, Ben-Av P, Hla T, Martinez A, Mulshine J, Malkani S, Chung P, Moody TW: Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res. 1998, 18: 775-782.","journal-title":"Anticancer Res"},{"key":"51_CR29","first-page":"4997","volume":"58","author":"H Wolff","year":"1998","unstructured":"Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 1998, 58: 4997-5001.","journal-title":"Cancer Res"},{"key":"51_CR30","first-page":"3761","volume":"58","author":"T Hida","year":"1998","unstructured":"Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998, 58: 3761-3764.","journal-title":"Cancer Res"},{"key":"51_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/j.1349-7006.1999.tb00717.x","volume":"90","author":"M Ochiai","year":"1999","unstructured":"Ochiai M, Oguri T, Isobe T, Ishioka S, Yamakido M: Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J Cancer Res. 1999, 90: 1338-1343.","journal-title":"Jpn J Cancer Res"},{"key":"51_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1615\/JEnvironPatholToxicolOncol.v21.i2.110","volume":"21","author":"T Takahashi","year":"2002","unstructured":"Takahashi T, Kozaki K, Yatabe Y, Achiwa H, Hida T: Increased expression of COX-2 in the development of human lung cancers. J Environ Pathol Toxicol Oncol. 2002, 21: 177-181.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"51_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0169-5002(00)00132-X","volume":"30","author":"Y Hosomi","year":"2000","unstructured":"Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, Ochiai A: Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer. 2000, 30: 73-81. 10.1016\/S0169-5002(00)00132-X.","journal-title":"Lung Cancer"},{"key":"51_CR34","first-page":"1","volume":"21","author":"TL Cornelison","year":"1997","unstructured":"Cornelison TL, Natarajan N, Piver MS, Mettlin CJ: Tubal ligation and the risk of ovarian carcinoma. Cancer Detect Prev. 1997, 21: 1-6.","journal-title":"Cancer Detect Prev"},{"key":"51_CR35","first-page":"903","volume":"10","author":"KB Moysich","year":"2001","unstructured":"Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H: Regular use of analgesic drugs and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2001, 10: 903-906.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"51_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","volume":"72","author":"O Suh","year":"1993","unstructured":"Suh O, Mettlin C, Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer. 1993, 72: 1171-1177.","journal-title":"Cancer"},{"key":"51_CR37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/oxfordjournals.aje.a115617","volume":"131","author":"C Mettlin","year":"1990","unstructured":"Mettlin C, Croghan I, Natarajan N, Lane W: The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol. 1990, 131: 973-983.","journal-title":"Am J Epidemiol"},{"key":"51_CR38","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.aje.a115747","volume":"132","author":"C Mettlin","year":"1990","unstructured":"Mettlin C, Natarajan N, Huben R: Vasectomy and prostate cancer risk. Am J Epidemiol. 1990, 132: 1056-1061.","journal-title":"Am J Epidemiol"},{"key":"51_CR39","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910430412","volume":"43","author":"C Mettlin","year":"1989","unstructured":"Mettlin C: Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer. 1989, 43: 608-612.","journal-title":"Int J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-2-31\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-2-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:33:29Z","timestamp":1726245209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-2-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-2-31","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,26]]},"assertion":[{"value":"17 October 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"31"}}